Fig. 7 From: Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIRMass spectrums of A Cabotegravir, B Rilpivirine, C DP1, D DP2, E DP3, F DP4Back to article page
